BH3-profiling therefore can identify cancer cells that are reliant on specific subsets of anti-apoptotic Bcl-2 proteins for survival, based upon the response to BH3-domain peptides with distinct binding specificities for those anti-apoptotic proteins39. The gene discussed is BCL2; the disease is cancer.